Patent ID: 9632090
Date: 2017-04-25
CPC Classifications: A61P,G01N

Claim:
1. A method of treating a subject afflicted with a benign liver hamartomatous tumor, the method comprising a) obtaining a subject sample comprising benign hamartomatous tumor tissue; b) generating a subject biomarker expression level, wherein said subject biomarker expression level is based on determining the level of expression of the Spry2 biomarker using a reagent which specifically binds with said Spry2 biomarker in the subject sample; c) determining the normal level of expression of said Spry2 biomarker in a control non-cancer sample; d) comparing the level of expression of said Spry2 biomarker in the subject sample relative to the normal level of expression of said Spry2 biomarker in the control non-cancer sample, wherein a significant decrease in the level of expression of said Spry2 biomarker in the subject sample and the normal level is an indication that the subject is afflicted with the benign liver hamartomatous tumor; and e) administering an anti-tumor agent to the subject determined to be afflicted with the benign liver hamartomatous tumor.